Charles River Laboratories International (CRL) Return on Equity (2016 - 2025)
Historic Return on Equity for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to 0.02%.
- Charles River Laboratories International's Return on Equity fell 1400.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.01% for FY2024, which is 1400.0% down from last year.
- Latest data reveals that Charles River Laboratories International reported Return on Equity of 0.02% as of Q3 2025, which was down 1400.0% from 0.02% recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Return on Equity ranged from a high of 0.18% in Q2 2021 and a low of 0.02% during Q3 2025
- In the last 5 years, Charles River Laboratories International's Return on Equity had a median value of 0.15% in 2023 and averaged 0.12%.
- Its Return on Equity has fluctuated over the past 5 years, first soared by 1400bps in 2021, then crashed by -1400bps in 2025.
- Charles River Laboratories International's Return on Equity (Quarter) stood at 0.16% in 2021, then grew by 9bps to 0.18% in 2022, then decreased by -21bps to 0.14% in 2023, then plummeted by -95bps to 0.01% in 2024, then tumbled by -437bps to 0.02% in 2025.
- Its Return on Equity stands at 0.02% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.